Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Sep 28, 2009
Finance
Ebb & Flow
...a portfolio manager for Lombard Odier and Cantrade, while Koller was an equity analyst at
UBS Warburg
...
Read More
BioCentury
|
Jun 5, 2006
Finance
Isis chronicles
...headcount to 480 from 505. E. 12/6/02 - ISIS drops $1.72 (22%) to $6.19 after
UBS Warburg
...
Read More
BioCentury
|
Apr 3, 2006
Finance
2nd Quarter Stock Preview: Small winners add up
...have managed to attract some new listings from U.K., Irish and some U.S. biotech companies,
UBS Warburg
...
Read More
BioCentury
|
May 9, 2005
Finance
Ebb & Flow
...director for healthcare at Lehman Brothers. He joined the firm in 2002 after working at
UBS Warburg
...
Read More
BioCentury
|
Jun 14, 2004
Finance
Ebb & Flow
...when it hoped to raise up to $50 million through Morgan Stanley; SG Cowen; and
UBS Warburg
...
Read More
BioCentury
|
Oct 6, 2003
Finance
Europe looks to follow-on
...see some IPOs next year," said Doug McCutcheon, managing director of healthcare corporate banking at
UBS Warburg
...
Read More
BioCentury
|
Aug 11, 2003
Finance
Ebb & Flow
...from $4.3 million in 2002. Spokesperson Joshua Grass said most of Tuesday's selling came after
UBS Warburg
...
Read More
BioCentury
|
May 26, 2003
Analyst Picks & Changes
Analyst picks & changes
...he expected a launch in the second half of 2004, with sales of $36 million.
UBS Warburg
...
Read More
BioCentury
|
May 19, 2003
Company News
The Aurora Funds management update
...Finance Hired: Greg Bohlen as CFO, formerly director of the Private Equity Coverage Group at
UBS Warburg
...
Read More
BioCentury
|
May 19, 2003
Finance
Ebb & Flow
...Greg Bohlen as CFO. Prior, he was director of the private equity coverage group at
UBS Warburg
...
Read More
Items per page:
10
1 - 10 of 255
BioCentury
|
Sep 28, 2009
Finance
Ebb & Flow
...a portfolio manager for Lombard Odier and Cantrade, while Koller was an equity analyst at
UBS Warburg
...
Read More
BioCentury
|
Jun 5, 2006
Finance
Isis chronicles
...headcount to 480 from 505. E. 12/6/02 - ISIS drops $1.72 (22%) to $6.19 after
UBS Warburg
...
Read More
BioCentury
|
Apr 3, 2006
Finance
2nd Quarter Stock Preview: Small winners add up
...have managed to attract some new listings from U.K., Irish and some U.S. biotech companies,
UBS Warburg
...
Read More
BioCentury
|
May 9, 2005
Finance
Ebb & Flow
...director for healthcare at Lehman Brothers. He joined the firm in 2002 after working at
UBS Warburg
...
Read More
BioCentury
|
Jun 14, 2004
Finance
Ebb & Flow
...when it hoped to raise up to $50 million through Morgan Stanley; SG Cowen; and
UBS Warburg
...
Read More
BioCentury
|
Oct 6, 2003
Finance
Europe looks to follow-on
...see some IPOs next year," said Doug McCutcheon, managing director of healthcare corporate banking at
UBS Warburg
...
Read More
BioCentury
|
Aug 11, 2003
Finance
Ebb & Flow
...from $4.3 million in 2002. Spokesperson Joshua Grass said most of Tuesday's selling came after
UBS Warburg
...
Read More
BioCentury
|
May 26, 2003
Analyst Picks & Changes
Analyst picks & changes
...he expected a launch in the second half of 2004, with sales of $36 million.
UBS Warburg
...
Read More
BioCentury
|
May 19, 2003
Company News
The Aurora Funds management update
...Finance Hired: Greg Bohlen as CFO, formerly director of the Private Equity Coverage Group at
UBS Warburg
...
Read More
BioCentury
|
May 19, 2003
Finance
Ebb & Flow
...Greg Bohlen as CFO. Prior, he was director of the private equity coverage group at
UBS Warburg
...
Read More
Items per page:
10
1 - 10 of 255
Previous page
Next page